We are live on
!
Find out more
Loomis, Sayles & Company Portfolio holdings
AUM
$74.3B
1-Year Est. Return
24.01%
This Fund
S&P 500
This Quarter
Est. Return
+1.17%
1 Year Est. Return
+24.01%
3 Year Est. Return
+109.67%
5 Year Est. Return
+145.58%
10 Year Est. Return
+623.12%
AUM
$47.1B
AUM Growth
-$899M
(-1.9%)
Cap. Flow
-$982M
Cap. Flow
% of AUM
-2.08%
Top 10 Holdings %
Top 10 Hldgs %
35.43%
Holding
967
New
122
Increased
219
Reduced
464
Closed
97
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Regeneron Pharmaceuticals
REGN
|
+$250M |
| 2 |
Starbucks
SBUX
|
+$152M |
| 3 |
CERN
Cerner Corp
CERN
|
+$122M |
| 4 |
Colgate-Palmolive
CL
|
+$87.1M |
| 5 |
Procter & Gamble
PG
|
+$77.4M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$456M |
| 2 |
Cisco
CSCO
|
+$392M |
| 3 |
Analog Devices
ADI
|
+$151M |
| 4 |
United Parcel Service
UPS
|
+$148M |
| 5 |
VAR
Varian Medical Systems, Inc.
VAR
|
+$89.7M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.05% |
| 2 | Consumer Discretionary | 15.92% |
| 3 | Financials | 12.69% |
| 4 | Healthcare | 12.47% |
| 5 | Communication Services | 9.69% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
EGOV
651
DELISTED
NIC Inc
EGOV
| $32K | ﹤0.01% |
2,379
+997
| +72% | +$14.8K |
|
|
ORIT
652
DELISTED
Oritani Financial Corp. New
ORIT
| $32K | ﹤0.01% |
2,103
+52
| +3% | +$836 |
|
|
XCRA
653
DELISTED
Xcerra Corporation
XCRA
| $32K | ﹤0.01% |
+2,729
| New | +$28.2K |
|
654
Diodes
DIOD
$4.84B
| $31K | ﹤0.01% |
1,034
| – | – |
|
655
Equinix
EQIX
$103B
| $31K | ﹤0.01% |
+74
| New | +$31.1K |
|
656
Iron Mountain
IRM
$36.1B
| $31K | ﹤0.01% |
+939
| New | +$31.6K |
|
657
Omega Healthcare
OHI
$14.7B
| $31K | ﹤0.01% |
+1,145
| New | +$30.5K |
|
|
PMT
658
PennyMac Mortgage Investment
PMT
$842M
| $31K | ﹤0.01% |
1,693
-492
| -23% | -$8.24K |
|
|
TECD
659
DELISTED
Tech Data Corp
TECD
| $31K | ﹤0.01% |
365
-21
| -5% | -$2.04K |
|
|
REXX
660
DELISTED
Rex Energy Corporation
REXX
| $31K | ﹤0.01% |
33,167
-6,149
| -16% | -$7.54K |
|
|
GCI
661
DELISTED
Gannett Co., Inc
GCI
| $31K | ﹤0.01% |
3,108
+243
| +8% | +$2.64K |
|
662
Equity Lifestyle Properties
ELS
$12.6B
| $30K | ﹤0.01% |
+688
| New | +$29.3K |
|
663
Extra Space Storage
EXR
$31.6B
| $30K | ﹤0.01% |
+342
| New | +$28.8K |
|
664
Jabil
JBL
$35.8B
| $30K | ﹤0.01% |
1,040
+85
| +9% | +$2.31K |
|
665
Progress Software
PRGS
$1.76B
| $30K | ﹤0.01% |
782
-79
| -9% | -$3.62K |
|
666
Public Storage
PSA
$61.3B
| $30K | ﹤0.01% |
+150
| New | +$29.2K |
|
667
Terreno Realty
TRNO
$7.49B
| $30K | ﹤0.01% |
+873
| New | +$30K |
|
668
W.P. Carey
WPC
$16.4B
| $30K | ﹤0.01% |
+496
| New | +$30.5K |
|
|
MDRX
669
DELISTED
Veradigm Inc. Common Stock
MDRX
| $30K | ﹤0.01% |
2,440
-268
| -10% | -$3.81K |
|
|
PSB
670
DELISTED
PS Business Parks, Inc.
PSB
| $30K | ﹤0.01% |
+262
| New | +$30.2K |
|
|
ALOG
671
DELISTED
Analogic Corp
ALOG
| $30K | ﹤0.01% |
310
+217
| +233% | +$18.8K |
|
672
Edison International
EIX
$26.4B
| $29K | ﹤0.01% |
+449
| New | +$27.7K |
|
673
Fortinet
FTNT
$117B
| $29K | ﹤0.01% |
+2,680
| New | +$26.1K |
|
|
TDAY
674
USA Today Co
TDAY
$1.06B
| $29K | ﹤0.01% |
1,663
+735
| +79% | +$12.3K |
|
675
Graham Holdings Company
GHC
$5.02B
| $29K | ﹤0.01% |
+48
| New | +$28.2K |
|
Similar funds
CBU
BC
Loomis, Sayles & Company's Q1 2018 Portfolio in Review
As of Q1 2018, Loomis, Sayles & Company held 967 positions worth $47.1B, down 1.9% from $48B the previous quarter. Its ten largest holdings account for 35% of the portfolio.
Loomis, Sayles & Company's Q1 2018 filing shows 122 new, 219 increased, 464 reduced and 97 closed positions. Its largest new stake was BioMarin Pharmaceuticals: 870,638 shares worth $70.6M. The largest sale was Amazon, an estimated $456M.
By sector, the portfolio is most concentrated in Technology at 18% of assets, down from 18% a quarter earlier, followed by Consumer Discretionary and Financials.
- Loomis, Sayles & Company's largest Q1 2018 buy was BioMarin Pharmaceuticals: 870,638 shares worth $70.6M.
- Loomis, Sayles & Company added most to Regeneron Pharmaceuticals in Q1 2018, an estimated $250M increase.
- Loomis, Sayles & Company's biggest Q1 2018 reduction was Amazon, cutting an estimated $456M.
- Loomis, Sayles & Company fully exited Analog Devices in Q1 2018, selling an estimated $151M.
- Loomis, Sayles & Company's ten largest holdings make up 35% of its $47.1B portfolio in Q1 2018.
- Loomis, Sayles & Company opened 122 new positions and closed 97 in Q1 2018.
- Loomis, Sayles & Company's portfolio value fell 1.9% quarter-over-quarter to $47.1B.
Based on Loomis, Sayles & Company's 13F filing for Q1 2018, filed 11 May 2018.